汎ぶどう膜炎治療の世界市場レポート 2025年

汎ぶどう膜炎治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5％で63億2,000万米ドルに成長します。予測期間の成長は、個別化医療へのアプローチ、新たな治療法、患者中心のケアへの注力、グローバルヘルスへの備え、精密医療への取り組み、ヘルスケア政策の変化などに起因すると考えられます。予測期間の主な動向には、相乗効果を狙った併用療法、遠隔医療と遠隔モニタリング、画像技術の進歩、人工知能の統合、世界的な共同研究などがあります。

眼関連疾患の有病率の増加は、今後の汎ぶどう膜炎治療市場の成長を促進すると予想されます。眼関連疾患は、眼疾患または眼病とも呼ばれ、眼の健康や機能に影響を及ぼす病状です。汎ぶどう膜炎治療は炎症を抑え、合併症を予防し、眼疾患に苦しむ患者の生活の質を向上させます。例えば、米国の公衆衛生機関である疾病管理予防センター（CDC）によると、2022年12月には、40歳以上の米国人のうち2,050万人が少なくとも1つの白内障を患っています。さらに、2028年までに約3,000万人が白内障眼疾患に罹患すると予測されています。したがって、眼関連疾患の有病率の増加が汎ぶどう膜炎治療市場を牽引しています。

自己免疫疾患の有病率の増加は、今後の汎ぶどう膜炎治療市場の成長を促進すると予測されています。自己免疫疾患の増加は、遺伝的要因、公害や食生活の変化などの環境的影響、免疫系の調節不全につながる可能性のある特定の感染症やストレス要因へのさらなる暴露が混在していることに起因しています。これらの疾患は、ぶどう膜炎の多くが自己免疫の活性と関連していることから、免疫系の調節に関する研究を促進し、ぶどう膜炎の治療法の進歩を促しています。例えば、2023年5月、英国の研究機関であるオックスフォード大学は、自己免疫疾患が世界人口の10％に影響を与え、女性の13％、男性の7％が罹患していると報告しました。このように、自己免疫疾患の有病率の上昇が汎ぶどう膜炎治療市場の拡大を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の汎ぶどう膜炎治療市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の汎ぶどう膜炎治療市場：成長率分析
• 世界の汎ぶどう膜炎治療市場の実績：規模と成長、2019～2024年
• 世界の汎ぶどう膜炎治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の汎ぶどう膜炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の汎ぶどう膜炎治療市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗炎症薬
• 抗菌薬
• 免疫療法と標的療法
• 世界の汎ぶどう膜炎治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 局所
• 世界の汎ぶどう膜炎治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他
• 世界の汎ぶどう膜炎治療市場：抗炎症薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイド
• 非ステロイド性抗炎症薬（NSAID）
• 世界の汎ぶどう膜炎治療市場：抗菌薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗生物質
• 抗真菌剤
• 抗ウイルス薬
• 世界の汎ぶどう膜炎治療市場：免疫療法と標的療法のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 生物学的製剤
• ヤヌスキナーゼ（JAK）阻害剤
• サイトカイン調節薬

第7章 地域別・国別分析

• 世界の汎ぶどう膜炎治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の汎ぶどう膜炎治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 汎ぶどう膜炎治療市場：競合情勢
• 汎ぶどう膜炎治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• Hoffmann-La Roche Ltd.
• Allergan Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Daiichi Sankyo Company Ltd.
• Horizon Therapeutics plc
• Hikma Pharmaceuticals PLC
• Santen Pharmaceutical Co. Ltd.
• Jubilant Life Sciences Ltd.
• HanAll Biopharma Inc.
• Xbrane Biopharma AB
• Alimera Science Inc.
• Ocular Therapeutix Inc.
• EyeGate Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 汎ぶどう膜炎治療市場2029：新たな機会を提供する国
• 汎ぶどう膜炎治療市場2029：新たな機会を提供するセグメント
• 汎ぶどう膜炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Panuveitis represents a severe inflammation affecting all layers of the eye's uvea, encompassing the iris, ciliary body, and choroid, with potential repercussions on the retina, vitreous humor, optic nerve, or eye lens. Timely and effective panuveitis treatment is crucial to mitigate inflammation, alleviate symptoms, and prevent vision loss or complications associated with the condition.

The primary drug classes employed in panuveitis treatment include anti-inflammatory medications, antimicrobial drugs, immunotherapy, and targeted therapies. Anti-inflammatory agents are substances or treatments specifically designed to reduce inflammation within the body. These therapeutic interventions can be administered through various routes, including oral and topical applications. Panuveitis treatments are utilized by diverse end-users such as hospitals, home care services, specialty clinics, and others.

The panuveitis treatment market research report is one of a series of new reports from The Business Research Company that provides panuveitis treatment market statistics, including panuveitis treatment industry global market size, regional shares, competitors with a panuveitis treatment market share, detailed panuveitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the panuveitis treatment industry. This panuveitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The panuveitis treatment market size has grown rapidly in recent years. It will grow from $3.98 billion in 2024 to $4.4 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased prevalence of uveitis, increased awareness and early diagnosis, improved drug delivery systems, patient advocacy initiatives, government support and regulatory approvals.

The panuveitis treatment market size is expected to see strong growth in the next few years. It will grow to $6.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to personalized medicine approaches, emerging therapeutic modalities, focus on patient-centric care, global health preparedness, precision medicine initiatives, healthcare policy changes. Major trends in the forecast period include combination therapies for synergistic effects, telemedicine and remote monitoring, advancements in imaging technologies, integration of artificial intelligence, global collaborations in research.

The increasing prevalence of eye-related diseases is expected to propel the growth of the panuveitis treatment market going forward. Eye-related diseases, also known as ocular diseases or eye conditions, are medical conditions that affect the health and function of the eyes. Panuveitis treatment reduces inflammation, prevents complications, and improves the quality of life for patients suffering from eye diseases. For instance, in December 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 20.5 million Americans over 40 had at least one cataract. Additionally, it is anticipated that approximately 30 million people will have cataract eye disease by 2028. Therefore, the increasing prevalence of eye-related diseases drives the panuveitis treatment market.

The increasing prevalence of autoimmune disorders is anticipated to drive the growth of the panuveitis treatment market in the future. The rise in autoimmune disorders can be attributed to a mix of genetic factors, environmental influences such as pollution and changes in diet, as well as greater exposure to specific infections and stressors that may lead to immune system dysregulation. These disorders are prompting advancements in panuveitis treatment by stimulating research into immune system modulation, as many panuveitis cases are associated with autoimmune activity. For example, in May 2023, the University of Oxford, a UK-based research institution, reported that autoimmune disorders impact 10% of the global population, affecting 13% of women and 7% of men. Consequently, the rising prevalence of autoimmune disorders is driving the expansion of the panuveitis treatment market.

Advancements in surgical interventions are anticipated to fuel the growth of the panuveitis treatment market in the coming years. Surgical procedures offer crucial treatment avenues for severe cases of panuveitis, addressing complications and aiding in restoring vision. These interventions encompass techniques such as vitrectomy, surgical removal of the vitreous gel in the eye, and implantation of devices or artificial intraocular lenses to manage panuveitis-related vision impairments. For example, in a clinical report published in June 2023 by the American Academy of Ophthalmology, innovative surgical approaches have shown promising outcomes in treating panuveitis complications, signifying a growing reliance on surgical interventions for managing the condition. Hence, advancements in surgical treatments are propelling the growth of the panuveitis treatment market.

Prominent enterprises engaged in the panuveitis treatment market are directing their efforts towards the development of innovative therapeutic solutions such as Xipere, aimed at providing enhanced and dependable services to their clientele. Xipere (triamcinolone acetonide) represents a corticosteroid administered via suprachoroidal injection to address macular edema induced by ocular inflammation. For instance, in February 2022, Clearside Biomedical Inc., a distinguished biopharmaceutical entity specializing in advanced drug delivery solutions for ocular diseases, introduced Xipere for treating macular edema linked to uveitis and panuveitis in the United States. Being the pioneering approved therapy containing triamcinolone acetonide, Xipere offers a preservative-free, sterile formulation designed specifically for suprachoroidal administration, utilizing Clearside's proprietary microinjector intended for the suprachoroidal space (SCS).

In July 2023, Harrow Health Inc., a US-based company, acquired Santen for an undisclosed amount. This acquisition allows Harrow to enhance its portfolio by integrating Santen's expertise in developing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd, based in Japan, specializes in providing treatments for panuveitis.

Major companies operating in the panuveitis treatment market report are Pfizer Inc., Johnson and Johnson Pvt. Ltd., Bausch Health Companies Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Allergan Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., Horizon Therapeutics PLC, Hikma Pharmaceuticals PLC, Santen Pharmaceutical Co. Ltd., Jubilant Life Sciences Ltd., HanAll Biopharma Inc., Xbrane Biopharma AB, Alimera Science Inc., Ocular Therapeutix Inc., EyeGate Pharmaceuticals Inc., Eyepoint Pharmaceuticals Inc., Graybug Vision Inc., Xoma Corporation, Tarsier Pharma Ltd., Vintage Labs Pvt. Ltd., Icon Bioscience Inc., Aciont Inc., Clearside Biomedical Inc., Aldeyra Therapeutics Inc.

North America was the largest region in the panuveitis treatment market in 2024. The regions covered in the panuveitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the panuveitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The panuveitis treatment market consists of revenues earned by entities by providing services such as immunosuppressive therapy, adjunctive therapies, and laser therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The panuveitis treatment market also includes sales of corticosteroids, biogenic agents, and intravitreal implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panuveitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panuveitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panuveitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Anti-Inflammatory; Antimicrobial Drugs; Immunotherapy And Targeted Therapies
• 2) By Route Of Administration: Oral; Topical
• 3) By End Users: Hospitals; Home Care; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Anti-Inflammatory: Corticosteroids; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 2) By Antimicrobial Drugs: Antibiotics; Antifungal Agents; Antiviral Medications
• 3) By Immunotherapy And Targeted Therapies: Biologic Agents; Janus Kinase (JAK) Inhibitors; Cytokine Modulators
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Pvt. Ltd.; Bausch Health Companies Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panuveitis Treatment Market Characteristics

3. Panuveitis Treatment Market Trends And Strategies

4. Panuveitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Panuveitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Panuveitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Panuveitis Treatment Market Growth Rate Analysis
• 5.4. Global Panuveitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Panuveitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Panuveitis Treatment Total Addressable Market (TAM)

6. Panuveitis Treatment Market Segmentation

• 6.1. Global Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Inflammatory
• Antimicrobial Drugs
• Immunotherapy And Targeted Therapies
• 6.2. Global Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• 6.3. Global Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Home Care
• Specialty Clinics
• Other End Users
• 6.4. Global Panuveitis Treatment Market, Sub-Segmentation Of Anti-Inflammatory, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• 6.5. Global Panuveitis Treatment Market, Sub-Segmentation Of Antimicrobial Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antifungal Agents
• Antiviral Medications
• 6.6. Global Panuveitis Treatment Market, Sub-Segmentation Of Immunotherapy And Targeted Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologic Agents
• Janus Kinase (JAK) Inhibitors
• Cytokine Modulators

7. Panuveitis Treatment Market Regional And Country Analysis

• 7.1. Global Panuveitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Panuveitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Panuveitis Treatment Market

• 8.1. Asia-Pacific Panuveitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Panuveitis Treatment Market

• 9.1. China Panuveitis Treatment Market Overview
• 9.2. China Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Panuveitis Treatment Market

• 10.1. India Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Panuveitis Treatment Market

• 11.1. Japan Panuveitis Treatment Market Overview
• 11.2. Japan Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Panuveitis Treatment Market

• 12.1. Australia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Panuveitis Treatment Market

• 13.1. Indonesia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Panuveitis Treatment Market

• 14.1. South Korea Panuveitis Treatment Market Overview
• 14.2. South Korea Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Panuveitis Treatment Market

• 15.1. Western Europe Panuveitis Treatment Market Overview
• 15.2. Western Europe Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Panuveitis Treatment Market

• 16.1. UK Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Panuveitis Treatment Market

• 17.1. Germany Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Panuveitis Treatment Market

• 18.1. France Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Panuveitis Treatment Market

• 19.1. Italy Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Panuveitis Treatment Market

• 20.1. Spain Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Panuveitis Treatment Market

• 21.1. Eastern Europe Panuveitis Treatment Market Overview
• 21.2. Eastern Europe Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Panuveitis Treatment Market

• 22.1. Russia Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Panuveitis Treatment Market

• 23.1. North America Panuveitis Treatment Market Overview
• 23.2. North America Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Panuveitis Treatment Market

• 24.1. USA Panuveitis Treatment Market Overview
• 24.2. USA Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Panuveitis Treatment Market

• 25.1. Canada Panuveitis Treatment Market Overview
• 25.2. Canada Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Panuveitis Treatment Market

• 26.1. South America Panuveitis Treatment Market Overview
• 26.2. South America Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Panuveitis Treatment Market

• 27.1. Brazil Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Panuveitis Treatment Market

• 28.1. Middle East Panuveitis Treatment Market Overview
• 28.2. Middle East Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Panuveitis Treatment Market

• 29.1. Africa Panuveitis Treatment Market Overview
• 29.2. Africa Panuveitis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Panuveitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Panuveitis Treatment Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Panuveitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Panuveitis Treatment Market Competitive Landscape
• 30.2. Panuveitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Panuveitis Treatment Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. Hoffmann-La Roche Ltd.
• 31.3. Allergan Inc.
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Regeneron Pharmaceuticals Inc.
• 31.6. Daiichi Sankyo Company Ltd.
• 31.7. Horizon Therapeutics plc
• 31.8. Hikma Pharmaceuticals PLC
• 31.9. Santen Pharmaceutical Co. Ltd.
• 31.10. Jubilant Life Sciences Ltd.
• 31.11. HanAll Biopharma Inc.
• 31.12. Xbrane Biopharma AB
• 31.13. Alimera Science Inc.
• 31.14. Ocular Therapeutix Inc.
• 31.15. EyeGate Pharmaceuticals Inc.

32. Global Panuveitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panuveitis Treatment Market

34. Recent Developments In The Panuveitis Treatment Market

35. Panuveitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Panuveitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Panuveitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Panuveitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer